FDG-PET/CT helps predict tuberculosis relapse
August 28, 2019 -- When FDG-PET/CT scans reveal lingering metabolic activity in the lungs of tuberculosis (TB) patients after treatment, approximately 10% of them will experience a relapse of the disease within six months, according to a study published online August 26 in the Journal of Nuclear Medicine.  Discuss
Which nuclear modality has the lowest dose for CHD?
August 21, 2019 -- Reducing radiation exposure from myocardial perfusion imaging is a key priority, especially for congenital heart disease (CHD) patients who face repetitive scanning. Which nuclear imaging modality and radiotracer are best for this task is the subject of a study published August 12 in the Journal of Nuclear Cardiology.  Discuss
NRC proposes changes to rules on radiotracer patients
August 15, 2019 -- The U.S. Nuclear Regulatory Commission (NRC) is proposing several updates in its regulatory guide on how best to handle patients who receive radioactive materials as part of their imaging scans.  Discuss
Study: FDG-PET reigns supreme for assessing Alzheimer's
August 9, 2019 -- FDG-PET is superior to amyloid PET imaging with the radiopharmaceutical florbetapir for assessing cognitive decline in patients with Alzheimer's disease or mild cognitive impairment, according to research published in the August issue of the Journal of Alzheimer's Disease.  Discuss
PSMA-PET/CT most effective for recurrent prostate cancer
August 7, 2019 -- PET/CT is significantly better at detecting prostate cancer recurrence when used with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) than with F-18 fluciclovine, according to an article recently published online in Lancet Oncology.  Discuss
Cardiologist self-referral of MPI remains a concern
August 6, 2019 -- Overall usage of standard myocardial perfusion imaging (MPI) exams has declined, but cardiologists are performing a higher share of these studies, according to research published in the August issue of the Journal of the American College of Radiology.  Discuss
Routine PET field-of-view enough for pediatric lymphoma
August 5, 2019 -- A routine "eyes to thighs" field-of-view with FDG-PET/CT scans is more than adequate to stage and monitor disease in a majority of pediatric patients with lymphoma, according to a study published in the August issue of the Journal of Nuclear Medicine.  Discuss
Unique combo camera merges PET, SPECT applications
August 1, 2019 -- Japanese researchers are reporting success in their first round of human imaging on a device that can simultaneously detect radiotracers used for PET and SPECT, according to a study published online July 20 in Physics in Medicine & Biology.  Discuss
Choline-PET with mpMRI is cost-effective for prostate cancer
July 31, 2019 -- Adding F-18 choline PET to multiparametric MRI (mpMRI) was more effective than mpMRI alone in determining which men with elevated prostate-specific antigen levels should go on to biopsy in a new study, published online July 26 in the Journal of Nuclear Medicine.  Discuss
Ga-68 PSMA PET with CT, MRI proves safe and accurate
July 30, 2019 -- Prostate cancer imaging with PET/CT or PET/MRI and a gallium-68 (Ga-68)-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical works well, according to a study published in the August issue of the American Journal of Roentgenology.  Discuss